Regeneron Pharmaceuticals Inc (MEX:REGN)
MXN 10,835.99 (0%) Market Cap: 1.23 Tn Enterprise Value: 1.13 Tn PE Ratio: 16.38 PB Ratio: 2.25 GF Score: 87/100

Regeneron Pharmaceuticals Inc at TD Cowen Healthcare Conference Transcript

Mar 04, 2026 / 02:10PM GMT
Release Date Price: MXN13790
Tyler Van Buren
TD Cowen - Analyst

Good morning, everyone. Tyler Van Buren here, senior biotech analyst at TD Cowen. Thank you very much for joining TD Cowen's 46th Annual Healthcare Conference.

For next session or first session of the day, actually, very excited to be hosting a fireside chat with Regeneron. And it's my pleasure to introduce Chris Fenimore, Executive Vice President of Finance and Chief Financial Officer; and Ryan Crowe, Senior Vice President, IR and Strategic Analysis for Regeneron.

Chris and Ryan, it's a privilege to have you here. Thank you very much for joining me.

Ryan Crowe
Regeneron Pharmaceuticals Inc - Senior Vice President of Investor Relations & Strategic Analysis

Thanks, Tyler. I think my shoes have finally dried out from the trudge in through the snow last night, but it's always great to be here at the TD Cowen Conference and looks like a great attendance. So thanks, everyone, for coming. Chris and I have a very compelling story to tell you today, I think, when you look at Regeneron and all the things we're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot